Both in Biotechnology
Lexeo Therapeutics vs Ocugen
Over the past year LXEO returned −65.6% and OCGN returned −51.6%; their daily moves had a correlation of 0.23.
LXEO −65.6% OCGN −51.6%Growth of $1, one year, split-adjusted
| Metric | LXEO | OCGN |
|---|---|---|
| Price | $3.11 | $0.7452 |
| Market cap | $255.3M | $252.7M |
| Today | +1.63% | +2.83% |
| 1 month | −8.8% | −28.3% |
| 6 months | −47.8% | −50.0% |
| Year to date | −68.7% | −44.8% |
| 1 year | −68.9% | −52.2% |
| Revenue growth (YoY) | — | +8.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1671.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $211.1M | $15.9M |
| Dividend yield | — | — |
| Volatility (60d) | 69.1% | 71.1% |
| Short % of float | 22.9% | 33.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).